Advanced Biological Laboratories SA (ABL) Release: HepatiC, HCV Patient Registry and Database to Aid in the Management of HCV-Infected Patients Receiving Direct Acting Antiviral Therapy
10/21/2013 9:51:21 AM
LUXEMBOURG--(BUSINESS WIRE)--Advanced Biological Laboratories (ABL) S.A. is pleased to announce the signing of a contract with the Spanish Association for the Study of the Liver (Asociación para el Estudio del Hídago, AEEH, www.aeeh.es) for the development and licensing of the new HepatiC™ software and database system. ABL undertakes the development, maintenance and upgrades and provides national access to the HepatiC™ program to the Spanish Community of Hepatologists to aid in the optimal personalized management of their HCV patients, especially those being treated with Direct Acting Antiviral (DAA) therapy.
Help employers find you! Check out all the jobs and post your resume.
comments powered by